Clin2
NCT07139431Possibly a fitNot yet recruiting

Imaging test for knee osteoarthritis cell therapy

KOA

Part of Bones, joints & muscles clinical trials.

This early-stage study tests a new imaging agent that may show how a cell therapy distributes in the body. It is specifically for people with knee osteoarthritis to help guide future treatments.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
6 people
Ages
40 years to 70 years
Study type
Interventional

Who can take part

  • You are between 40 and 70 years old
  • You have been diagnosed with knee osteoarthritis and have had knee pain for more than 6 months
  • You have not had knee surgery on the affected knee
  • You have not had stem cell therapy or recent injections/supplements for knee pain (within the last 3 months)
  • You do not have other joint problems in your hip or ankle that need treatment
  • You are not overweight (BMI below 30)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06741098Not yet recruiting· Phase 1/Phase 2
Stem cell injection for knee osteoarthritis pain

This study tests a new stem cell treatment injected into the knee to see if it can reduce pain and improve function in people with knee osteoarthritis. It may be an option for those who have had persistent knee pain for more than six months.

NCT06549686Recruiting· Phase 3
Knee osteoarthritis treatment study with cell therapy

This trial tests a new cell-based treatment (CLS2901C) for knee osteoarthritis. It combines the treatment with a realignment surgery (proximal tibial osteotomy) to help repair cartilage damage and reduce pain.

Ebina, Kanagawa
NCT06570291Recruiting· Phase 3
Stem cell injection for knee osteoarthritis

This trial tests a new treatment using donor stem cells injected into the knee for people with moderate knee osteoarthritis. It aims to see if these cells can reduce pain and improve function.

Shanghai, China
NCT06343714Recruiting· Phase 1
Testing a new drug for knee osteoarthritis pain

This study tests a new antibody drug (FB1003) for people with knee osteoarthritis pain. It will check if the drug is safe and helps reduce pain. You may be eligible if you have moderate to severe knee pain and are willing to temporarily stop your usual pain medications.

Brisbane, Queensland
NCT07106229Not yet recruiting· Phase 3
Knee injection for osteoarthritis pain

This trial tests a new knee injection called MAG200. It may reduce knee pain and make daily activities easier.

NCT07473414Recruiting
Knee tissue study for early osteoarthritis treatment

This trial studies knee tissue to find better ways to diagnose early osteoarthritis. It may help people who need a knee injection for pain relief.

Nantes

Hear when a new KOA trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.